Hubert Sagnieres, the French executive vice-chairman of eyewear group EssilorLuxottica, hit back at criticism of him by the company’s top shareholder and executive chairman, Italian billionaire
Australians living with, or are at risk of macular disease, will soon benefit from $3 million funding by the Australian government.Announcing the package, Australia's health ministry said it
Macular Degeneration New Zealand’s (MDNZ’s) Professional Friends network profiles member optometrists and ophthalmologists on MDNZ’s website and gives them free access to essential resources, like Amsler grids and nutritional guidance for patients. It also helps cover the cost of MDNZ’s vital public
Inserting a single gene in blind mice gave them back their sight, said scientists, adding the treatment could be being tested in humans in as little as three years. A month after University of
Patients diagnosed with migraine headaches are at least 20% more likely to have dry eye disease (DED) than those without migraines, according to a study by University of North Carolina
A new study casts doubt on the effectiveness of laser peripheral iridotomy treatment, used commonly around the world as a preventative measure for people at risk of developing primary angle closure
Researchers at the University of New Hampshire (UNH) have created a hydrogel which could be made into a contact lens to more effectively treat corneal melting. Often injectable hydrogels are applied
Massachusetts University scientists claim to have given mammals night vision to see light beyond the visible spectrum and into the range of infrared light. The vision enhancement, done with a simple
Researchers in Oxford say they have carried out the world’s first gene therapy operation to tackle the root cause of age-related macular degeneration (AMD). The procedure was carried out at the John
An international glaucoma study showed use of the Glaukos iStent trabecular micro-bypass stent during cataract surgery delivered a 38% reduction in mean intraocular pressure (IOP) to 14.7 mmHg after
The US Food and Drug Administration (FDA) has upgraded a recall of the Raindrop corneal inlay to Class 1, its highest level used for devices with the potential to cause serious injuries or death.RVO
With an Australian election imminent, Optometry Australia has launched its election campaign, calling for all sides of government to support its vision for a sustainable and effective eye care system
